Brokerages Expect Orthopediatrics Corp (NASDAQ:KIDS) to Post -$0.22 EPS

Share on StockTwits

Wall Street brokerages expect that Orthopediatrics Corp (NASDAQ:KIDS) will post ($0.22) earnings per share (EPS) for the current fiscal quarter, Zacks reports. Three analysts have provided estimates for Orthopediatrics’ earnings. The lowest EPS estimate is ($0.27) and the highest is ($0.18). Orthopediatrics reported earnings of ($0.19) per share in the same quarter last year, which would suggest a negative year over year growth rate of 15.8%. The firm is expected to report its next earnings report on Wednesday, March 4th.

On average, analysts expect that Orthopediatrics will report full-year earnings of ($0.82) per share for the current year, with EPS estimates ranging from ($0.88) to ($0.76). For the next financial year, analysts forecast that the business will post earnings of ($0.35) per share, with EPS estimates ranging from ($0.55) to ($0.15). Zacks’ earnings per share averages are a mean average based on a survey of sell-side research analysts that that provide coverage for Orthopediatrics.

Orthopediatrics (NASDAQ:KIDS) last posted its earnings results on Thursday, November 7th. The company reported ($0.18) EPS for the quarter, missing the consensus estimate of ($0.17) by ($0.01). The business had revenue of $20.74 million during the quarter, compared to analysts’ expectations of $19.87 million. Orthopediatrics had a negative net margin of 15.80% and a negative return on equity of 12.22%. The business’s quarterly revenue was up 31.1% compared to the same quarter last year. During the same period last year, the company earned ($0.15) EPS.

Several equities analysts recently commented on KIDS shares. Piper Jaffray Companies increased their target price on Orthopediatrics from $40.00 to $44.00 and gave the company an “overweight” rating in a report on Friday. Zacks Investment Research upgraded shares of Orthopediatrics from a “hold” rating to a “buy” rating and set a $42.00 price objective for the company in a research note on Tuesday. ValuEngine downgraded shares of Orthopediatrics from a “buy” rating to a “hold” rating in a research note on Thursday, August 1st. Finally, BidaskClub downgraded shares of Orthopediatrics from a “buy” rating to a “hold” rating in a research note on Friday. Two research analysts have rated the stock with a hold rating and five have given a buy rating to the company’s stock. The company presently has an average rating of “Buy” and an average target price of $45.40.

Several institutional investors and hedge funds have recently made changes to their positions in the company. Calamos Advisors LLC bought a new stake in Orthopediatrics in the 2nd quarter valued at $2,373,000. Vanguard Group Inc. raised its holdings in shares of Orthopediatrics by 4.8% in the second quarter. Vanguard Group Inc. now owns 457,646 shares of the company’s stock valued at $17,848,000 after purchasing an additional 20,799 shares during the last quarter. BlackRock Inc. increased its holdings in Orthopediatrics by 16.8% during the second quarter. BlackRock Inc. now owns 585,555 shares of the company’s stock worth $22,837,000 after buying an additional 84,205 shares during the last quarter. Russell Investments Group Ltd. acquired a new position in Orthopediatrics during the second quarter worth $2,055,000. Finally, Bank of America Corp DE boosted its position in Orthopediatrics by 9.9% during the second quarter. Bank of America Corp DE now owns 35,316 shares of the company’s stock worth $1,377,000 after purchasing an additional 3,175 shares during the period. Institutional investors and hedge funds own 50.42% of the company’s stock.

NASDAQ:KIDS traded up $0.57 during trading hours on Tuesday, hitting $38.07. The company’s stock had a trading volume of 3,028 shares, compared to its average volume of 53,956. The stock has a market capitalization of $560.23 million, a P/E ratio of -39.66 and a beta of 0.23. The stock has a fifty day moving average of $36.27 and a 200-day moving average of $36.99. The company has a current ratio of 2.53, a quick ratio of 1.75 and a debt-to-equity ratio of 0.24. Orthopediatrics has a 52-week low of $25.11 and a 52-week high of $47.82.

About Orthopediatrics

OrthoPediatrics Corp., a medical device company, designs, develops, and markets anatomically appropriate implants and devices for the treatment of children with orthopedic conditions in the United States and internationally. The company's products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail products, PediLoc tibia products, anterior cruciate ligament reconstruction systems, locking cannulated blades, locking proximal femurs, RESPONSE Spine systems, Bandloc, and Pediguard.

See Also: What does the Producer Price Index (PPI) tell investors?

Get a free copy of the Zacks research report on Orthopediatrics (KIDS)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Orthopediatrics (NASDAQ:KIDS)

Receive News & Ratings for Orthopediatrics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Orthopediatrics and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


 
© 2006-2019 BBNS.